Dengue Fever Cases Rising Rapidly in Eastern Malaysia

Malaysia's Sandakan district reported the highest number of dengue cases of the debilitating disease at 319, followed by Kota Kinabalu at 152 and Tawau with 72.

Between January and March 10, Malaysia's eastern Sabah state has recorded 913 cases of dengue fever, marking an increase of 70 cases compared to the same period last year, the media reported.

The state's Health Department Director Christina Rundi said the coastal Sandakan district reported the highest number of cases of the debilitating disease at 319, followed by Kota Kinabalu at 152 and Tawau with 72, out of the total number of cases in the state, EFE news reported.

Wearable Mosquito Repellent 'Clip-on' Offers Protection Against Zika, Dengue
Clip-On caused high mosquito mortality and knockdown rates good enough to protect a single person wearing the device.

‘Dengue control and prevention activities have been conducted in 112 localities, with inspections being carried out in 12,014 premises.’

However, the number of dengue cases could have been much higher in Sandakan, as following the month-long Dengue Control and Prevention Mega Operation, which ends on March 15, case numbers had fallen by 96 percent in the district, she said.

Under that operation, dengue control and prevention activities have been conducted in 112 localities, with inspections being carried out in 12,014 premises. Insecticide fogging was also carried out in 150 localities.

Source-IANS

Malaysia Witness More Than 50 Percent Rise in Dengue Deaths
In Malaysia, a total of 336 people - an average of 28 a month - died from dengue last year compared to 215 in 2014, a rise of 56.3 percent.

Rio De Janeiro Fights Dengue Fever Explosion Ahead of 2016 Olympics
Rio de Janeiro launched an operation to wipe out dengue fever-carrying mosquitoes, after an explosion of cases of the potentially deadly tropical disease.

Sanofi's First Vaccine to Prevent Dengue Fever Gets Brazilian Government's Approval
The dengue vaccine, Dengvaxia, manufactured by the French pharmaceutical giant Sanofi has received approval from regulators in three countries.